NS-041

Depression

Phase 1IND approved

Key Facts

Indication

Depression

Phase

Phase 1

Status

IND approved

Company

A major integrated Chinese pharmaceutical group with strong R&D in microsphere technology, biologics, and traditional Chinese medicine.

Drug	Company	Phase	Status
Undisclosed Programs	Johnson and Johnson Innovative Medicine	Pipeline	Active
Depression Clinical Trials	IMA Clinical Research	Not Applicable (Service)	Active
Depression Study	Sun Valley Research Center	Not Disclosed	Active
eTNS Platform	NeuroSigma	Unknown	Active
ALM003	Almatica Pharma	Phase 3	Active
ALM014	Almatica Pharma	Pivotal BA/BE	Active
NRCT-101SR	Neurocentria	Phase 2b/3	Active
Starstim for Depression	Neuroelectrics	Phase 1/2	Active
Depression Biomarkers	Paradise Genomics	Discovery	Active
Home-tDCS Depression Trial	Soterix Medical	N/A (Device-enabled trial)	Active
BPL-003	AtaiBeckley	Phase 2	Active
VLS-01	AtaiBeckley	Phase 2	Active